Ophthalmology · Jacksonville, FL
NPI
1336139187
Since 2005
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
11512 Lake Mead Ave, Unit 534
Jacksonville, FL, 32256
Phone (904) 642-2222
Groups this clinician bills Medicare through
Medicare paid, 2024
$226K
6,017 services
Medicare patients, 2024
880
Average age 76
Drug cost, 2024
$974K
527 prescriptions
Company payments, 2025
$12K
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David A Kostick was code J0588 (injection, incobotulinumtoxin a, 1 unit), 3,710 times for 25 patients. In total David A Kostick billed 6,017 services in 65 codes, and Medicare paid $226K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-12-30.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0588 Injection, incobotulinumtoxin a, 1 unit | Office | 3,710 | 25 | $3.76 | $14K |
| 92285 Standard X-ray | Office | 643 | 613 | $15.57 | $10K |
| 99213 Office E&M - Established | Office | 246 | 230 | $67.21 | $17K |
| 92012 Ophthalmological E&M | Office | 163 | 158 | $52.25 | $8,517 |
| 99214 Office E&M - Established | Office | 141 | 136 | $97.57 | $14K |
| 99204 Office E&M - New | Office | 116 | 116 | $120.06 | $14K |
| 92082 Vision, Hearing, and Speech Services | Office | 113 | 108 | $33.17 | $3,748 |
| 92002 Ophthalmological E&M | Office | 107 | 107 | $48.62 | $5,202 |
| 99203 Office E&M - New | Office | 80 | 80 | $80.80 | $6,464 |
| 68840 Eye | Office | 79 | 75 | $115.10 | $9,093 |
| 31231 Nasal/Sinus Endoscopy | Office | 66 | 62 | $87.30 | $5,762 |
| 99212 Office E&M - Established | Office | 62 | 60 | $42.59 | $2,640 |
| 64612 Musculoskeletal | Office | 57 | 25 | $125.95 | $7,179 |
| 92083 Vision, Hearing, and Speech Services | Office | 54 | 43 | $46.16 | $2,493 |
| 92014 Ophthalmological E&M | Office | 38 | 31 | $86.86 | $3,301 |
By year: 2022 $222K for 5,075 services; 2023 $237K for 6,903 services; 2024 $226K for 6,017 services.
Medicare prescription drug claims, 2024
In 2024, the drug David A Kostick prescribed most often to Medicare patients was Neomycin-Polymyxin-Dexameth (Neomycin/Polymyxin B/Dexametha), with 269 prescriptions and refills. In total David A Kostick wrote 527 Medicare prescriptions that cost $974K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 269 | 282 | 168 | $4,753 |
| Erythromycin Erythromycin Base | 176 | 178 | 123 | $2,350 |
| Tepezza Teprotumumab-Trbw | 13 | 13 | Under 11 | $955K |
Brand drugs: 140 claims; generic drugs: 387 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David A Kostick $12K ($12K in general payments such as food, travel and fees) from 5 companies. The largest payer was Amgen Inc. with $12K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.